COST-EFFECTIVENESS ANALYSIS OF DIMETHYL FUMARATE IN THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY

被引：0
|
作者：
Mantovani, L. G. [1 ]
Furneri, G. [2 ]
Cortesi, P. A. [1 ]
Puma, E. [3 ]
Santoni, L. [3 ]
Prosperini, L. [4 ]
机构：
[1] Univ Milano Bicocca, Milan, Italy
[2] EBMA Consulting SRL, Melegnano, Italy
[3] Biogen, Milan, Italy
[4] S Camillo Forlanini Hosp, Rome, Italy
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND24
引用
下载
收藏
页码：S740 / S741
页数：2
相关论文
共 50 条
  • [41] The cost-effectiveness of disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis
    Bozkaya, Duygu
    Livingston, Terrie
    Migliaccio-Walle, Kristen
    Odom, Tanner
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (03) : 297 - 302
  • [42] Cost-Effectiveness of Natalizumab Compared With Fingolimod for Relapsing-Remitting Multiple Sclerosis Treatment in Colombia
    Lasalvia, Pieralessandro
    Hernandez, Fabian
    Castaneda-Cardona, Camilo
    Andres Cuestas, J.
    Rosselli, Diego
    VALUE IN HEALTH REGIONAL ISSUES, 2020, 23 : 13 - 18
  • [43] DIMETHYL FUMARATE VERSUS FINGOLIMOD AND TERIFLUNOMIDE FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN COLOMBIA: A COST-UTILITY ANALYSIS
    Ordonez, J. E.
    VALUE IN HEALTH, 2017, 20 (05) : A194 - A194
  • [44] Dimethyl fumarate: A guide to its use in relapsing-remitting multiple sclerosis
    Keating G.M.
    Burness C.B.
    Deeks E.D.
    Drugs & Therapy Perspectives, 2014, 30 (9) : 303 - 308
  • [45] Real world experience with dimethyl fumarate in relapsing-remitting multiple sclerosis
    Cox, S. R.
    Jordan, S.
    Sharma, D.
    O'Boyle, G.
    Tubridy, N.
    Hutchinson, M.
    Mcguigan, C.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 614 - 615
  • [46] EXTENDING THERAPEUTIC POSSIBILITIES IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: DIMETHYL FUMARATE
    Matolcsi Judit
    Rozsa Csilla
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2015, 68 (1-2): : 7 - 14
  • [47] Acute pancreatitis: possible association of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis
    Luo, Hongxiu
    Bhatt, Harsh
    Mohamad, Shaza
    Uhrik, Eric
    Sen, Shuvendu
    Mathew, Teena
    Yousif, Abdalla
    JOURNAL OF NEUROLOGY, 2015, 262 (03) : 779 - 780
  • [48] Dimethyl Fumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis: Patient Reported Outcomes and Perspectives
    Ozel, Osman
    Vaughn, Caila B.
    Eckert, Svetlana P.
    Jakimovski, Dejan
    Lizarraga, Alexis A.
    Weinstock-Guttman, Bianca
    PATIENT-RELATED OUTCOME MEASURES, 2019, 10 : 373 - 384
  • [49] Actual adherence to dimethyl fumarate in patients with relapsing-remitting multiple sclerosis
    de Sa, Joao
    Ferreira, Joao
    Macedo, Ana M.
    REVISTA DE NEUROLOGIA, 2023, 76 : S1 - S6
  • [50] COST-EFFECTIVENESS ANALYSIS OF PEGINTERFERON BETA-1A IN THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN SCOTLAND
    Hernandez, L.
    Guo, S.
    Toro-Diaz, H.
    Carroll, S.
    Farooq, Syed S. F.
    VALUE IN HEALTH, 2015, 18 (07) : A756 - A756
12345